tashatuvango -stock.adobe.com The collaboration comes on the heels of J&J winning approval from the Japanese Ministry of Health, Labour and Welfare for a contact lens that provides vision correction and an antihistamine drug to help relieve symptoms for people experiencing itchy allergy eyes.
Johnson & Johnson Vision is teaming up with Menicon, a developer of contact lenses to address myopia or near-sightedness in children.
The pact calls for Menicon to develop the contact lenses that would manage the progression of myopia. J&J Vision would focus on expanding the availability of the products across the world.
“For decades, Johnson & Johnson Vision has invested in research collaborations with academic centers, research institutes and leading global health organizations who share our vision of leading with science to reshape the future of myopia and eye health,” said Peter Menziuso, Global President, Johnson & Johnson Vision Care. “Our collaborati
Small Cap Wrap - Mast Energy Developments, Critical Metals, Zephyr Energy and more
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
OKYO Pharma Limited appoints chief scientific officer
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
OKYO Pharma LTD: OKYO Pharma Limited (OKYO or the Company) - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: This is an image of RPE implant embedded in the sub-retinal space of a non-human primate model. The background retinal vessels highlighted by fundus fluorescein angiography. view more
Credit: Su, Xinyi
Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et al recently published in
Stem Cell Reports. The retinal pigment epithelium (RPE), a layer of pigmented cells in the retina, is essential for sustaining normal vision. Blindness due to RPE dysfunction, such as macular degeneration, affects about 200 million people worldwide.